Invalidation by medical professionals in post-treatment Lyme disease.
Gender
Invalidation
Lyme disease
Post-treatment Lyme disease
Quality-of-life
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 08 2024
21 08 2024
Historique:
received:
29
11
2023
accepted:
19
08
2024
medline:
22
8
2024
pubmed:
22
8
2024
entrez:
21
8
2024
Statut:
epublish
Résumé
Patients with post-treatment Lyme disease (PTLD) report negative perceptions of care and significant invalidation from medical professionals. However, the relationship of invalidation to illness severity has not been examined, nor have risk factors for invalidation been identified. This cross-sectional study enrolled 80 patients who met stringent criteria for PTLD. We examined correlations between the Illness Invalidation Inventory and measures of symptom severity, quality of life, and trust in physicians. To study the relationship between invalidation and potential demographic and clinical factors, we generated simple unadjusted and multivariate adjusted linear regression models. We found that higher 'lack of understanding' and 'discounting' subscale scores of the Illness Invalidation Inventory were significantly positively correlated with higher symptom severity, lower quality of life, and lower trust in physicians. In adjusted linear regression models, older age (lack of understanding: β = - 0.17, p = 0.008, discounting: β = - 0.19, p = 0.001, every 10 years) and male gender (lack of understanding: β = - 0.49, p = 0.016, discounting: β = - 0.51, p = 0.006) were associated with less invalidation. We also identified receiving an alternative diagnosis for PTLD as a mediator in the relationship between gender and invalidation. Based on our findings, we hypothesize that reducing invalidation within the clinical encounter could positively affect illness burden and quality of life for patients with PTLD.
Identifiants
pubmed: 39169257
doi: 10.1038/s41598-024-70556-7
pii: 10.1038/s41598-024-70556-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
19406Informations de copyright
© 2024. The Author(s).
Références
Steere, A. C. et al. Lyme borreliosis. Nat. Rev. Dis. Primers 2, 16090. https://doi.org/10.1038/nrdp.2016.90 (2016).
pubmed: 27976670
pmcid: 5539539
Rebman, A. et al. The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome. Front. Med. (Lausanne) 4, 224. https://doi.org/10.3389/fmed.2017.00224 (2017).
pubmed: 29312942
Aucott, J. N., Seifter, A. & Rebman, A. W. Probable late Lyme disease: A variant manifestation of untreated Borrelia burgdorferi infection. BMC Infect. Dis. 12, 173. https://doi.org/10.1186/1471-2334-12-173 (2012).
pubmed: 22853630
pmcid: 3449205
Rebman, A. W. & Aucott, J. N. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Front. Med. (Lausanne) https://doi.org/10.3389/fmed.2020.00057 (2020).
pubmed: 33324657
DeLong, A., Hsu, M. & Kotsoris, H. Estimation of cumulative number of post-treatment Lyme disease cases in the US, 2016 and 2020. BMC Public Health 19, 352. https://doi.org/10.1186/s12889-019-6681-9 (2019).
pubmed: 31014314
pmcid: 6480773
Choutka, J., Jansari, V., Hornig, M. & Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med 2022(28), 911–923. https://doi.org/10.1038/s41591-022-01810-6 (2022).
Ballantyne, C. The chronic debate over Lyme disease. Nat. Med. 14, 1135–1139. https://doi.org/10.1038/nm1108-1135 (2008).
Brown, P., Morello-Frosch, R. & Zavestoski, S. Contested Illnesses: Citizens, Science, and Health Social Movements (University of California Press, 2012).
Dumit, J. Illnesses you have to fight to get: facts as forces in uncertain, emergent illnesses. Soc. Sci. Med. 62, 577–590. https://doi.org/10.1016/j.socscimed.2005.06.018 (2006).
pubmed: 16085344
Rebman, A. et al. Living in limbo: contested narratives of patients with chronic symptoms following Lyme disease. Qual Health Res 27, 534–546. https://doi.org/10.1177/1049732315619380 (2017).
pubmed: 26631681
Kool, M. B., Van Middendorp, H., Boeije, H. R. & Geenen, R. Understanding the lack of understanding: Invalidation from the perspective of the patient with fibromyalgia. Arthritis Rheum. 61, 1650–1656. https://doi.org/10.1002/ART.24922 (2009).
pubmed: 19950317
Kool, M. B. et al. Lack of understanding in fibromyalgia and rheumatoid arthritis: the Illness Invalidation Inventory (3*I). Ann. Rheum. Dis. 69, 1990–1995. https://doi.org/10.1136/ard.2009.123224 (2010).
pubmed: 20498203
Ali, A. et al. Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study. BMC Fam Pract 15, 79. https://doi.org/10.1186/1471-2296-15-79 (2014).
pubmed: 24885888
pmcid: 4012507
Mechanic, D. & Meyer, S. Concepts of trust among patients with serious illness. Soc. Sci. Med. 51, 657–668 (2000).
pubmed: 10975226
Baarsma, M. E. et al. Knowing the entire story – a focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease). BMC Primary Care 23, 1–12. https://doi.org/10.1186/S12875-022-01736-5/TABLES/1 (2022).
Nesgos, A. T., Harrington, L. C. & Mader, E. M. Experience and knowledge of Lyme disease: A scoping review of patient-provider communication. Ticks Tick Borne Dis. 12, 101714. https://doi.org/10.1016/J.TTBDIS.2021.101714 (2021).
pubmed: 33780825
pmcid: 10044390
Kool, M. B. et al. Measurement invariance of the Illness Invalidation Inventory (3*I) across language, rheumatic disease and gender. Ann. Rheum. Dis. 73, 551–556. https://doi.org/10.1136/ANNRHEUMDIS-2012-201807 (2014).
pubmed: 23413282
Kendrick, E. A. & Beesley, D. Perceived stress, illness invalidation, and symptom severity in myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue Biomed. Health Behav. 4, 217–225. https://doi.org/10.1080/21641846.2016.1250862 (2016).
Molzof, H. E. et al. Validating invalidation: Examining the construct validity of the Illness Invalidation Inventory among individuals with chronic low back pain. Clin. J. Pain https://doi.org/10.1097/AJP.0000000000000817 (2020).
pubmed: 32068539
Samulowitz, A., Gremyr, I., Eriksson, E. & Hensing, G. “Brave men” and “emotional women”: A theory-guided literature review on gender bias in health care and gendered norms towards patients with chronic pain. Pain Res. Manag. 2018, 1–14. https://doi.org/10.1155/2018/6358624 (2018).
Paganini, G. A., Summers, K. M., ten Brinke, L. & Lloyd, E. P. Women exaggerate, men downplay: Gendered endorsement of emotional dramatization stereotypes contributes to gender bias in pain expectations. J Exp. Soc. Psychol. 109, 104520. https://doi.org/10.1016/J.JESP.2023.104520 (2023).
pubmed: 38046638
Zhang, L. et al. Gender Biases in Estimation of Others’ Pain. J Pain 22, 1048–1059. https://doi.org/10.1016/J.JPAIN.2021.03.001 (2021).
pubmed: 33684539
pmcid: 8827218
Wormser, G. P. et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 43, 1089–1134. https://doi.org/10.1086/508667 (2006).
pubmed: 17029130
Kool, M. B. et al. Social support and invalidation by others contribute uniquely to the understanding of physical and mental health of patients with rheumatic diseases. J. Health Psychol. 18, 86–95. https://doi.org/10.1177/1359105312436438 (2013).
pubmed: 22363049
Ware, J. E., Kosinski, M. & Dewey, J. E. How to score version 2 of the SF-36 health survey (Quality Metric Inc., 2000).
Hall, M. A., Camacho, F., Dugan, E. & Balkrishnan, R. Trust in the medical profession: conceptual and measurement issues. Health Serv. Res. 37, 1419–1439. https://doi.org/10.1111/1475-6773.01070 (2002).
pubmed: 12479504
pmcid: 1464022
Costello, A. B. & Osborne, J. W. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract. Assess. Res. Eval. https://doi.org/10.7275/JYJ1-4868 (2005).
Tingley, D. et al. mediation: R package for causal mediation analysis. J. Stat. Softw. https://doi.org/10.18637/jss.v059.i05 (2014).
Ghavidel-Parsa, B. et al. Correlation of invalidation with symptom severity and health status in fibromyalgia. Rheumatology 54, 482–486. https://doi.org/10.1093/RHEUMATOLOGY/KEU355 (2015).
pubmed: 25205826
Ghavidel-Parsa B, Bidari A (2020) Two sides on the fibromyalgia coin: physical pain and social pain (invalidation). Clinical Rheumatology 2020 40:3 40:841–848. https://doi.org/10.1007/S10067-020-05304-Z
Eisenberger, N. I. The Neural Bases of Social Pain. Psychosom Med 74, 126–135. https://doi.org/10.1097/PSY.0b013e3182464dd1 (2012).
pubmed: 22286852
pmcid: 3273616
Leschak, C. J. & Eisenberger, N. I. Two distinct immune pathways linking social relationships with health: Inflammatory and antiviral processes. Psychosom Med 81, 711–719. https://doi.org/10.1097/PSY.0000000000000685 (2019).
pubmed: 31600173
pmcid: 7025456
Reiche, E. M. V., Nunes, S. O. V. & Morimoto, H. K. Stress, depression, the immune system, and cancer. Lancet Oncol. 5, 617–625. https://doi.org/10.1016/S1470-2045(04)01597-9 (2004).
pubmed: 15465465
Sloan, M. et al. ‘But you don’t look sick’: A qualitative analysis of the LUPUS UK online forum. Rheumatol. Int. 41, 721. https://doi.org/10.1007/S00296-020-04726-X (2021).
pubmed: 33104839
Durif-Bruckert, C., Roux, P. & Rousset, H. Medication and the patient-doctor relationship: A qualitative study with patients suffering from fibromyalgia. Health Expect. 18, 2584–2594. https://doi.org/10.1111/HEX.12230 (2015).
pubmed: 24995371
Bontempo, A. C. The effect of personalized invalidation of symptoms by healthcare providers on patient depression: The mediating role of self-esteem. Patient Educ. Couns. 105, 1598–1605. https://doi.org/10.1016/J.PEC.2021.09.034 (2022).
pubmed: 34666932
Boring, B. L., Walsh, K. T., Nanavaty, N. & Mathur, V. A. Shame mediates the relationship between pain invalidation and depression. Front. Psychol. 12, 5673. https://doi.org/10.3389/FPSYG.2021.743584/BIBTEX (2021).
Kool, M. B. & Geenen, R. Loneliness in patients with rheumatic diseases: The significance of invalidation and lack of social support. J. Psychol. 146, 229–241. https://doi.org/10.1080/00223980.2011.606434 (2012).
pubmed: 22303622
Magni, G., Moreschi, C., Rigatti-Luchini, S. & Merskey, H. Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain 56, 289–297. https://doi.org/10.1016/0304-3959(94)90167-8 (1994).
pubmed: 8022622
Currie, S. & Wang, J. More data on major depression as an antecedent risk factor for first onset of chronic back pain. Psychol. Med. 35, 1275–1282. https://doi.org/10.1017/S0033291705004952 (2005).
pubmed: 16168150
Fricker, M. Epistemic Injustice: Power and the Ethics of Knowing (Oxford University Press, 2007).
Blease, C., Carel, H. & Geraghty, K. Epistemic injustice in healthcare encounters: evidence from chronic fatigue syndrome. J. Med. Ethics 43, 549–557. https://doi.org/10.1136/MEDETHICS-2016-103691 (2017).
pubmed: 27920164
Stewart, M. et al. The impact of patient-centered care on outcomes. J. Family Pract. 49, 796–804 (2000).
Centers for Disease Control and Prevention (1995) Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 44:590–591